Kenneth Knudson Joins Profound Medical as Chief Commercial Officer
TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device...
Day: January 5, 2022
Maravai LifeSciences Announces Registration and Webcast Information for Upcoming R&D Day, to be Held on January 28, 2022
SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life...
Alimera Sciences to Participate in Upcoming January 2022 Investor Conferences
ATLANTA, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a...
Morphic Therapeutic to Present at the Virtual 40th Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of...
T-knife Therapeutics Appoints Ronald Krasnow, J.D., as General Counsel
SAN FRANCISCO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a biopharmaceutical company dedicated to developing novel therapeutics to...
F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in Immuno-Oncology Collaboration
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical...
Werewolf Therapeutics to Present at the H.C. Wainwright Bioconnect Conference
CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical...
Black Diamond Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass. and NEW YORK, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology...
Mersana Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ: MRSN) a clinical-stage biopharmaceutical company focused on discovering...
Sientra Announces Acquisition of Novel Fat Grafting Technology from AuraGen Aesthetics, LLC
Broadens Sientra’s opportunity within the estimated $13 billion U.S. plastic surgery market1 with the addition of a highly differentiated, FDA-cleared...
Halberd Corporation Now an Official US Government Contractor
Halberd to bid on Additional Federal Contracts with the Federal GovernmentJackson Center, Pennsylvania--(Newsfile Corp. - January 5, 2022) - Halberd...
Awakn Life Sciences Expands World’s First Ketamine Study Beyond Gambling Disorder to Include Additional Behavioral Addictions
Groundbreaking Psychedelic Study Will Investigate Binge Eating Disorder, Compulsive Sexual Behavior, and Internet Gaming DisorderToronto, Ontario--(Newsfile Corp. - January 5,...
Stephanie Reisinger to Lead Flatiron Health’s Real-World Evidence Business
Former Veradigm Executive Brings Extensive Experience in EHR-Derived Real-World Data NEW YORK--(BUSINESS WIRE)--Flatiron HealthⓇ today announced the appointment of Stephanie...
Hologic Adds Aptima SARS-CoV-2 Assay to its Global Access Initiative in Resource-Limited Countries
MARLBOROUGH, Mass.--(BUSINESS WIRE)--#Africa--Hologic, Inc. (NASDAQ: HOLX) announces the addition of the Aptima® SARS-CoV-2 assay to its Global Access Initiative (GAI),...
Leiden University Medical Center and Intravacc to Start Clinical Trial with New Intranasal Corona Vaccine
Nasal spray vaccine based on soluble nano-spheres with synthetic corona proteinsNo use of mRNA or vector technologyBetter and direct immunization...
Relief Therapeutics to Participate in Virtual Investor Conferences in January
GENEVA, SWITZERLAND / ACCESSWIRE / January 5, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), a...